Parametric Portfolio Associates’s Nu Skin NUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $19.9M | Buy |
415,026
+28,403
| +7% | +$1.41M | 0.01% | 958 |
|
|
2021
Q4 | $19.6M | Buy |
386,623
+17,073
| +5% | +$759K | 0.01% | 967 |
|
|
2021
Q3 | $15M | Buy |
369,550
+122,225
| +49% | +$6.18M | 0.01% | 1093 |
|
|
2021
Q2 | $14M | Sell |
247,325
-14,654
| -6% | -$834K | 0.01% | 1157 |
|
|
2021
Q1 | $13.9M | Sell |
261,979
-4,529
| -2% | -$247K | 0.01% | 1414 |
|
|
2020
Q4 | $14.6M | Buy |
266,508
+39,120
| +17% | +$2.06M | 0.01% | 1285 |
|
|
2020
Q3 | $11.4M | Buy |
227,388
+31,020
| +16% | +$1.47M | 0.01% | 1305 |
|
|
2020
Q2 | $7.51M | Buy |
196,368
+9,900
| +5% | +$318K | 0.01% | 1590 |
|
|
2020
Q1 | $4.07M | Buy |
186,468
+7,122
| +4% | +$214K | ﹤0.01% | 1890 |
|
|
2019
Q4 | $7.35M | Sell |
179,346
-29,589
| -14% | -$1.21M | 0.01% | 1765 |
|
|
2019
Q3 | $8.89M | Buy |
208,935
+59,966
| +40% | +$2.52M | 0.01% | 1546 |
|
|
2019
Q2 | $7.35M | Buy |
148,969
+7,944
| +6% | +$404K | 0.01% | 1708 |
|
|
2019
Q1 | $6.75M | Sell |
141,025
-10,099
| -7% | -$612K | 0.01% | 1741 |
|
|
2018
Q4 | $9.27M | Sell |
151,124
-35,496
| -19% | -$2.39M | 0.01% | 1387 |
|
|
2018
Q3 | $15.4M | Buy |
186,620
+15,296
| +9% | +$1.22M | 0.01% | 1096 |
|
|
2018
Q2 | $13.4M | Buy |
171,324
+7,391
| +5% | +$573K | 0.01% | 1129 |
|
|
2018
Q1 | $12.1M | Buy |
163,933
+7,972
| +5% | +$566K | 0.01% | 1191 |
|
|
2017
Q4 | $10.6M | Sell |
155,961
-2,817
| -2% | -$182K | 0.01% | 1286 |
|
|
2017
Q3 | $9.76M | Buy |
158,778
+24,449
| +18% | +$1.5M | 0.01% | 1274 |
|
|
2017
Q2 | $8.44M | Buy |
134,329
+22,919
| +21% | +$1.31M | 0.01% | 1328 |
|
|
2017
Q1 | $6.19M | Sell |
111,410
-5,282
| -5% | -$272K | 0.01% | 1553 |
|
|
2016
Q4 | $5.58M | Buy |
116,692
+8,737
| +8% | +$489K | 0.01% | 1564 |
|
|
2016
Q3 | $6.99M | Buy |
107,955
+12,481
| +13% | +$702K | 0.01% | 1250 |
|
|
2016
Q2 | $4.41M | Buy |
95,474
+9,709
| +11% | +$391K | 0.01% | 1647 |
|
|
2016
Q1 | $3.28M | Buy |
85,765
+16,268
| +23% | +$538K | 0.01% | 1987 |
|
|
2015
Q4 | $2.63M | Buy |
69,497
+15,162
| +28% | +$559K | ﹤0.01% | 2003 |
|
|
2015
Q3 | $2.24M | Sell |
54,335
-5,009
| -8% | -$215K | ﹤0.01% | 1762 |
|
|
2015
Q2 | $2.8M | Sell |
59,344
-4,382
| -7% | -$237K | 0.01% | 1928 |
|
|
2015
Q1 | $3.84M | Buy |
63,726
+13,242
| +26% | +$674K | 0.01% | 1597 |
|
|
2014
Q4 | $2.21M | Buy |
50,484
+4,702
| +10% | +$208K | ﹤0.01% | 2094 |
|
|
2014
Q3 | $2.06M | Sell |
45,782
-19,706
| -30% | -$1.05M | ﹤0.01% | 2044 |
|
|
2014
Q2 | $4.84M | Sell |
65,488
-13,456
| -17% | -$1.06M | 0.01% | 1216 |
|
|
2014
Q1 | $6.54M | Sell |
78,944
-72,987
| -48% | -$6.41M | 0.02% | 954 |
|
|
2013
Q4 | $21M | Buy |
151,931
+52,863
| +53% | +$6.22M | 0.05% | 405 |
|
|
2013
Q3 | $9.48M | Buy |
99,068
+35,370
| +56% | +$3M | 0.03% | 685 |
|
|
2013
Q2 | $3.89M | Buy |
+63,698
| New | +$3.54M | 0.01% | 1152 |
|
Other funds holding NUS
ACB
Parametric Portfolio Associates's NUS Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Nu Skin (NUS) stake by 7.3% in Q1 2022, buying an estimated $1.41M and bringing the position to 415,026 shares worth $19.9M. The position accounts for 0.01% of the portfolio, ranked #958.
Parametric Portfolio Associates first reported a position in NUS in Q2 2013 and has held it in 36 quarters since. The position peaked at $21M in Q4 2013. 238 funds tracked by Wall St. Rank hold NUS as of Q1 2022.
- Parametric Portfolio Associates held 415,026 shares of Nu Skin worth $19.9M as of Q1 2022.
- Parametric Portfolio Associates bought 28,403 Nu Skin shares in Q1 2022, an estimated $1.41M.
- Nu Skin made up 0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #958 holding.
- Parametric Portfolio Associates first reported a position in Nu Skin in Q2 2013 and has held it in 36 quarters since.
- Parametric Portfolio Associates's Nu Skin position peaked at $21M in Q4 2013.
- 238 funds tracked by Wall St. Rank held Nu Skin as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.